JM DUTTON HEALTH CONFERENCE IN NEW YORK WED SEPT 24

J.M. Dutton Associates is hosting its Biotech, Medical & Healthcare Conference on Wednesday, September 24, at the Harvard Club in New York. The conference, hosted in conjunction with Friedland Capital, Inc., features presentations by a eleven companies in JM Dutton's healthcare research universe. It gives members of the financial community the opportunity to meet with senior executives of companies in this exciting field and the JM Dutton analysts covering them. The Conference is being webcast live and click here for details on attendance or to hear the presentations.

Presenting at the conference are:

• Aastrom Biosciences, Inc. (ASTM)
• Amarin Corporation (AMRN)
• BioSante Pharmaceuticals, Inc. (BISP)
• Calypte Biomedical (CYPT)
• CytoGenix, Inc. (CYGX)
• GlycoGenesys, Inc. (GLGS)
• IntegraMed America, Inc (INMD)
• Molecular Imaging Corp. (MLRI)
• Neurobiological Technologies (NTII)
• Pharmos Corporation (PARS)
• Trinity Biotech plc (TRIB)

The conference runs from 8 a.m. to 2:15 p.m. at the Harvard Club of New York, 27 West 44th Street (between 5th and 6th). It includes lunch and features a luncheon presentation by Sherry Grisewood, CFA, JM Dutton's assistant director of research who will speak on trends in healthcare.

An audio webcast of the conference will be available "live" and then archived for 60 days at www.friedlandcapitalevents.com/duttonwebcast.htm . Profiles of the presenting companies are featured in this month's Buyside Magazine.

The conference is open to members of the financial community, including private equity investors, portfolio/fund managers, corporate finance advisors, investment bankers, brokers and other buy-side and sell-side professionals.

Tickets are required for admittance. If interested in attending, please go to www.friedlandcapitalevents.com/dutton.htm or call 212-757-9454.